[PLX] QoQ Quarter Result on 31-Mar-2013 [#Q1]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
09-May-2013
Financial Year
2013
Quarter
31-Mar-2013 [#Q1]
Profit Trend
QoQ- 56.25%
YoY- 26.81%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Revenue 1,122 3,359 3,064 3,968 48 5,390 26,113 -87.66%
PBT -10,885 -5,747 -6,837 -4,321 968 -5,479 22 -
Tax 0 0 0 0 -1,741 -81 -8,765 -
NP -10,885 -5,747 -6,837 -4,321 -9,877 -5,479 9,642 -
Tax Rate - - - - 179.86% - 39,840.91% -
Total Cost 12,007 9,106 9,901 8,289 9,925 10,869 16,471 -18.95%
Ratio Analysis
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
NP Margin -970.14 -171.09 -223.14 -108.90 -20,577.08 -101.65 36.92 -
Per Share
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
EPS -1.18 -0.06 -0.07 -0.05 -1.07 -0.06 0.11 -
EPS Diluted -1.17 -0.06 -0.07 -0.05 -1.07 -0.06 0.10 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.